Biograil
- Business Model
- B2B
- Website
- biograil.com
About
Breakthrough technology for the oral delivery of biologics
Summary
Biograil is a biotechnology company based in Denmark.
Similar Companies
C
CrucellAcquired
Novel vaccine platform
Leiden, Netherlands201–500biotechnology, pharmaceuticals
Venture Round·$97.0M·Jan 2001
EyePointIPO
Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...
Watertown, United States51–200biotechnology, Manufacturing
Corporate Round·$60.5M·Mar 2018
ActelionAcquired
Small molecule therapies for cardiovascular diseases
Allschwil, Switzerland1001–5000biotechnology, pharmaceuticals
Funding undisclosed
BridgeBioIPO
BridgeBio makes targeted treatments for genetic diseases.
San Francisco Bay Area, United States201–500Biotech, Life Sciences
Growth Equity·$1.7B·Jan 2024
Seattle GeneticsAcquired
Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
Bothell, United States1001–5000biotechnology, cancer_treatment
Corporate Round·$1.0B·Sep 2020
BT
Bicycle TherapeuticsIPO
Novel bicyclic peptides and drug conjugates for cancer
Cambridge, United States201–500Biotech, oncology
Private Equity·$555.0M·Jan 2024